Teva Pharmaceutical to Cease Production at Plant in Cidra, Puerto Rico
Teva Pharmaceutical Industries Ltd. announced that the company will cease production at its manufacturing facility in Cidra, Puerto Rico during the fourth quarter of 2006.
Petak Tikva, Israel (Aug. 23)-Teva Pharmaceutical Industries Ltd. (www.tevapharm.com) announced that the company will cease production at its manufacturing facility in Cidra, Puerto Rico during the fourth quarter of 2006. Teva says the move is designed to further improve efficiencies, supply chain management, and competitive positioning following its acquisition of Ivax earlier this year.
The former Ivax facility at Cidra has roughly 550 employees and originally manufactured 50 products. Teva says the majority of these products have already been transferred to other manufacturing facilities. Teva expects that the move will achieve an estimated $45 million in cost savings in 2007.
Teva's manufacturing facility for active pharmaceutical ingredients in Puerto Rico is not affected by the closure.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
